View Cart (0 items)
Pharmaceutical

H1N1 vaccine is top flu concern for U.S. businesses

October 01, 2009
/ Print / Reprints /
| Share More
/ Text Size+
The number-one H1N1 flu concern among U.S. businesses is the availability of a vaccine for employees, according to a new survey by the Business Roundtable. The organization also found that nearly 90-percent of businesses surveyed have activated or updated their crisis plans since an outbreak of the H1N1 influenza in April 2009. Thirty-five percent of the survey respondents said they need more information about the severity of H1N1 pandemic flu compared to seasonal flu. Member companies in the Business Roundtable represent one-third of the U.S. economy, including 10 million workers. The group launched the survey several months ago in order to measure how well businesses were preparing for H1N1 and its potential effects on employees, customers, and operations.
You must login or register in order to post a comment.